openPR Logo
Press release

Pulmonary Drug Delivery Devices Market Size will Grow Profitably in the Near Future

08-31-2018 10:34 AM CET | Health & Medicine

Press release from: Transparency Market Research

Pulmonary Drug Delivery Devices Market Size will Grow

Due to limitations of the conventional treatment of various chronic diseases, attention has been shifted to the development of targeted drug delivery systems. Pulmonary drug delivery is one of the targeted drug delivery systems where the drug delivery is aimed at lungs for local and systemic treatment. The high permeability and large absorptive surface area of lungs, along with steady blood supply, leads to faster absorption of drugs into the bloodstream. Increased adoption of pulmonary drug delivery is expected to push the global pulmonary drug delivery systems market during the period between 2013 and 2019.

Obtain Report Details @ https://www.transparencymarketresearch.com/pulmonary-drug-delivery-systems.html

Increasing Patient Base to Boost Global Pulmonary Drug Delivery Systems Market

According to the World Health Organization, around 300 million people across the globe suffer from asthma. Growing patient pool affected with respiratory diseases such as asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD) is one of the prime factors set to contribute to the global pulmonary drug delivery systems market.

Rapid absorption of different macromolecules and most of the therapeutic drugs over the alveolar epithelium of the distal lung has allowed pulmonary drug delivery systems to become efficacious. Technical advances in pulmonary drug delivery systems as well as drug formulations are expected to propel the overall market in the near future. Presently, the therapeutic applications of pulmonary drug delivery are expanding and this will help the market’s growth prospects.

Request for Sample Copy of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=873

However, patent expiry of drug delivery systems and delay in obtaining approvals from regulatory authorities are expected to negatively affect the global pulmonary drug delivery systems market. During the next couple of years, developing economies will present immense market potential for pulmonary drug delivery systems, owing to the growing patient base.

Nebulizers to be Fastest Growing Segment of Global Pulmonary Drug Delivery Systems Market

On the basis of product type, the global pulmonary drug delivery systems market has been segmented into nebulizers, metered dose inhalers (MDIs), and dry powder inhalers (DPIs). In 2012, the overall market was dominated by metered dose inhalers, which accounted for 56.8% of the market. Dry powder inhalers were the second largest segment in the market the same year. During the period between 2013 and 2019, nebulizers are expected to be the fastest growing segment of the pulmonary drug delivery systems market. In terms of application, the global pulmonary drug delivery systems market has been categorized into cystic fibrosis, asthma, and chronic obstructive pulmonary disease (COPD). In the coming years, the usage of pulmonary drug delivery systems for the treatment of asthma and COPD is expected to increase considerably.

Request Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=873

North America Led Global Pulmonary Drug Delivery Systems Market in 2012

Globally, the pulmonary drug delivery systems market has been divided into four key regions: Europe, Asia Pacific, North America, and Rest of the World. In 2012, North America was the leading market for pulmonary drug delivery systems, owing to the increasing patient base and robust healthcare infrastructure. During the period between 2013 and 2019, Asia Pacific is expected to contribute significantly to the growth of the market due to the growing number of people smoking tobacco. Some of the key players in the global pulmonary drug delivery systems market are CareFusion Corporation, 3M Health Care, Novartis AG, Omron Healthcare Inc., and GlaxoSmithKline.

Popular Research Reports by TMR –

Post-operative Nausea and Vomiting Market: http://markets.businessinsider.com/news/stocks/post-operative-nausea-and-vomiting-market-to-become-worth-us-3-100-mn-by-2026-says-tmr-1027343575

Sterilization Wrap Market: http://www.prnewswire.co.uk/news-releases/sterilization-equipment-market-to-gain-us-846553-mn-by-2026-says-tmr-687864421.html

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pulmonary Drug Delivery Devices Market Size will Grow Profitably in the Near Future here

News-ID: 1213874 • Views:

More Releases from Transparency Market Research

Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights for the USD 15.9 Bn Market 2022-2031
Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights f …
The global handheld marijuana vaporizer market has witnessed remarkable growth in recent years, attributed to the increasing acceptance of medicinal marijuana and the demand for convenient and discreet consumption methods. Valued at US$ 5 billion in 2021, the market is projected to surge at a CAGR of 13.4% to reach US$ 15.9 billion by 2031. This article delves into the factors driving this growth, the evolving market landscape, and the
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And Competitors
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And …
The COVID-19 pandemic has precipitated a remarkable surge in the demand for disinfectant products, with a notable emphasis on disinfectant wipes as an essential tool in maintaining hygiene and preventing the spread of pathogens. This research report delves into the multifaceted landscape of the disinfectant wipes market, elucidating key trends, drivers, and innovations shaping the industry. 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐩𝐨𝐫𝐭 @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=70359 Key Players and Market Developments Key players
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Study
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Stud …
The global 𝐭𝐢𝐬𝐬𝐮𝐞 𝐛𝐚𝐧𝐤𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 reached a value of US$ 1,056.4 million in 2017 and is projected to nearly triple to US$ 2,903.3 million by 2026, with a robust Compound Annual Growth Rate (CAGR) of approximately 12.0% from 2018 to 2026. Factors such as increasing awareness about tissue donation, technological advancements, and a growing target patient population are anticipated to propel market growth during this period. Moreover, the market is expected
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
This report by Transparency Market Research, Inc. assesses the present state and future growth potential of the global 𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐜𝐥𝐨𝐬𝐮𝐫𝐞 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭. It features a comprehensive executive summary, offering insights into various segments of the market. Additionally, the report provides detailed analysis and data on product, access type, application, end user, and regional segments within the global market. Vascular closure devices is estimated to reach a value of ~US$ 1 Bn

All 5 Releases


More Releases for Pulmonary

Global Pulmonary Arterial Hypertension Market Size
According to a new market research report published by Global Market Estimates, the Global Pulmonary Arterial Hypertension Market is projected to grow at a CAGR of 5.2% from 2022 to 2027. Congenital heart diseases and other ailments such as HIV infection, chronic liver disease (cirrhosis), and connective tissue disorders (scleroderma, lupus, and others) are fueling market expansion. Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC
New Study: Pulmonary Drugs Market Report
The pulmonary drugs market is expected to witness unprecedented growth in the near future, thanks to large number of approvals from the FDA. The FDA approved a large number of pulmonary drugs for major illnesses like small-cell lung cancer, tuberculosis, and pneumonia over the past few years. Additionally, newly approved drugs also treat newly found diseases like obstructive sleep apnea. These approvals are in line with the recent trend of
Pulmonary Drugs Market Forecast till 2025
Pulmonary Drugs Market – Boon for Diseased Lungs Pulmonary drugs can treat wide range of conditions, which are included within the ambit of pulmonary diseases such as pneumonia, allergic rhinitis, pulmonary hypertension, and others. . Pulmonary drugs provide medications for all types of pulmonary diseases, which is expected to fuel market growth in near future. The World Health Organization (WHO) states that most respiratory diseases are preventable and can be treated
Pulmonary Embolism - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Pulmonary Embolism - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pulmonary Embolism - Pipeline Review, H2 2017, provides an overview of the Pulmonary Embolism (Cardiovascular) pipeline landscape. Pulmonary embolism is the sudden blockage of a major blood vessel (artery) in the lung, usually by a blood
Pulmonary Drugs 2024 Market Research Report
Global Pulmonary Drugs Market: Snapshot The global pulmonary drugs market has been the key area of focus and the most crucial market for the healthcare industry in the last couple of years. However, the market is expected to witness a significant decline over the forecast period with a -6.3% CAGR from 2016 to 2024. The market is anticipated to fall to US$28,082.1 mn from a valuation of US$48,039.7 mn in
03-15-2017 | Health & Medicine
TMR
Pulmonary Drug Delivery Devices Market: Demand for Pulmonary Drug Delivery Devic …
This report on pulmonary drug delivery devices studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various pulmonary/respiratory drugs and/or drug-device combinations as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments